The 2024 GLOBOCAN report highlights a projected increase in the global burden of cancer from 20 million new diagnoses in 2022, to 35 million in 2050.1 Radiotherapy and theranostics: a Lancet Oncology ...
Radiotherapy and theranostics are crucial in cancer management, with more than 50% of patients with cancer needing ...
In 2015, the Lancet Oncology Commission on expanding global access to radiotherapy laid out the first evidence-based case for global investment in radiotherapy by showing substantial health and ...
The 2015 Lancet Oncology Commission on expanding global access to radiotherapy1 was a pivotal moment in global oncology. It highlighted disparities in radiotherapy access and revealed radiotherapy ...
Drug shortages are becoming more severe around the world.1 The causes of worsening drug shortages in Japan include the impact of a large-scale campaign to switch from brand name to generic drugs and a ...
Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. A 57-year-old woman with a ...
Copyright: © 2024 Elsevier Ltd. Published by Elsevier Ltd. More than a million doses have also been promised to African countries in the coming year. Paul Adepoju ...
aCentral Referral Veterinary Hospital, Department of Livestock Services, Tripureshwar, Kathmandu, Nepal ...
aEnvironment and Health Research Unit, South African Medical Research Council, Cape Town 7501, South Africa bEnvironment and Health Research Unit, South African Medical Research Council, Pretoria, ...
Copyright: © 2024 Published by Elsevier Ltd. In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback